Metraipolis › archive › dc_f702d1379d80
DDX5 (p68) and UbE2T as emerging superior cancer therapeutic targets: dual molecular glue target degradation by FL118 for conquering difficult-to-treat cancers — Europe PMC PMID:42152107
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42152107
- DOI
- 10.1186/s13046-[numero omesso]-3
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T05:27:13.842Z
- SHA-256 of the archived text
08c504a1f74f176c4535d33457936aa41230114ba76edea66364d5bb8e5cfc22- Stable URL of this page
https://metraipolis.com/documento/dc_f702d1379d80
How to cite
DDX5 (p68) and UbE2T as emerging superior cancer therapeutic targets: dual molecular glue target degradation by FL118 for conquering difficult-to-treat cancers — Europe PMC PMID:42152107 — Europe PMC (en), https://europepmc.org/article/MED/42152107 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f702d1379d80 (Metraipolis archive dc_f702d1379d80, sha256 08c504a1f74f176c4535d33457936aa41230114ba76edea66364d5bb8e5cfc22)
BibTeX
@misc{dcf702d1379d80,
title = {DDX5 (p68) and UbE2T as emerging superior cancer therapeutic targets: dual molecular glue target degradation by FL118 for conquering difficult-to-treat cancers — Europe PMC PMID:42152107},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42152107},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f702d1379d80; sha256 08c504a1f74f176c4535d33457936aa41230114ba76edea66364d5bb8e5cfc22},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42152107. Agents can read the archived copy with the MCP tool read_document.